Literature DB >> 16051902

Inhibition of rho-kinase in the nucleus tractus solitarius enhances glutamate sensitivity in rats.

Koji Ito1, Yoshitaka Hirooka, Nobuaki Hori, Yoshikuni Kimura, Yoji Sagara, Hiroaki Shimokawa, Akira Takeshita, Kenji Sunagawa.   

Abstract

The Rho/Rho-kinase pathway in the central nervous system is involved in the maintenance of dendritic spines, which form the postsynaptic contact sites of excitatory synapses. Inhibition of the Rho-kinase pathway in neuron promotes dendritic spines or branches. In contrast, activation of the Rho/Rho-kinase pathway reduces dendritic spines or branches. Recent studies suggest that morphological changes of dendritic spines occur rapidly, and spine morphology is associated with glutamate sensitivity. The aim of the present study was to determine whether Rho-kinase activity affects glutamate sensitivity in the nucleus tractus solitarii (NTS) of Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). We first examined the effects of unilateral glutamate injection in the NTS. There was a significantly smaller decrease in arterial pressure in SHR than in WKY. We then examined the depressor responses evoked by unilateral glutamate injection into the NTS after preinjection of Y-27632, a specific Rho-kinase inhibitor. Preinjection of Y-27632 enhanced the glutamate response in both strains. However, the magnitude of the augmentation was significantly greater in SHR than in WKY. Furthermore, we recorded single-unit activity of NTS neurons from medulla brain slice preparations. N-methyl-D-aspartate (NMDA) or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) was applied iontophoretically to the recorded neurons, and neuronal activity was recorded before and after Y-27632 perfusion. Y-27632 perfusion increased the response to NMDA and AMPA. These results suggest that inhibition of Rho-kinase activity in the NTS enhances glutamate sensitivity in WKY and SHR and might improve impaired glutamate sensitivity in SHR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051902     DOI: 10.1161/01.HYP.00001747119.23178.05

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

2.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

3.  Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits.

Authors:  Peter R Pellegrino; Alicia M Schiller; Karla K V Haack; Irving H Zucker
Journal:  Hypertension       Date:  2016-09-26       Impact factor: 10.190

4.  Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Salim Yalcin Inan; Burak Cem Soner; Ayse Saide Sahin
Journal:  Metab Brain Dis       Date:  2016-03-21       Impact factor: 3.584

5.  Sustained hypertension increases the density of AMPA receptor subunit, GluR1, in baroreceptive regions of the nucleus tractus solitarii of the rat.

Authors:  Sam M Hermes; Jennifer L Mitchell; Marc B Silverman; Patrick J Lynch; Brenda L McKee; Timothy W Bailey; Michael C Andresen; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-24       Impact factor: 3.252

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.